Abstract
Human colon adenocarcinoma (Caco-2) cells, when grown on semipermeable filters, spontaneously differentiate in culture to form confluent monolayers which both structurally and functionally resemble the small intestinal epithelium. Because of this property they show promise as a simple, in vitro model for the study of drug absorption and metabolism during absorption in the intestinal mucosa. In the present study, the transport of several model solutes across Caco-2 cell monolayers grown in the Transwell ™ diffusion cell system was examined. Maximum transport rates were found for the actively transported substance glucose and the lipophilic solutes testosterone and salicylic acid. Slower rates were observed for urea, hippurate, and salicylate anions and were correlated with the apparent partition coefficient of the solute. These results are similar to what is found with the same compounds in other, in vivo absorption model systems. It is concluded that the Caco-2 cell system may give useful predictions concerning the oral absorption potential of new drug substances.
Similar content being viewed by others
REFERENCES
I. Osiecka, P. A. Porter, R. T. Borchardt, J. A. Fix, and C. R. Gardner. Pharm. Res. 2:284–292 (1985).
W. H. Barr and S. Riegelman. J. Pharm. Sci. 59:154–163 (1970).
F. Raul, M. Kedinger, P. Simon, J. Grenier, and K. Haffen. Biol. Cell 3:163–168 (1978).
A. Quaroni, J. Wands, R. L. Trelstad, and K. J. Isselbacher. J. Cell Biol. 80:248–265 (1979).
M. Pinto, S. Ronine-Leon, M. D. Appay, M. Kidinger, N. Triadov, E. Dussaulx, B. Lacroix, P. Simon-Assmann, K. Hoffen, J. Fogh, and A. Zwiebaum. Biol. Cell 47:323–330 (1983).
M. Pinto, M. D. Appay, and P. Simon-Assmann. Biol. Cell 44:193–196 (1982).
A. Zweibaum, N. Triadov, M. Kedinger, C. Augeron, S. Robine-Leon, M. Pinto, M. Rousset, and K. Haffen. Int. J. Cancer 32:407–412 (1983).
A. Zweibaum, H. P. Hauri, E. Sterchi, I. Chantret, K. Haffen, J. Bamat, and B. Sordat. Int. J. Cancer 34:591–598 (1984).
H. P. Hauri, E. E. Sterchi, D. Bienz, J. A. M. Fransen, and A. Marker. J. Cell Biol. 101:838–851 (1985).
E. Grasset, J. Bernareu, and M. Pinto. Am. J. Physiol. 248:C410–C418 (1985).
I. Mohrmann, M. Mohrmann, J. Biber, and H. Muren. Am. J. Physiol. 250:G323–G330 (1986).
M. Rousset. Biochemie 60:1035–1040 (1986).
A. Quaroni. J. Natl. Cancer Inst. 76:571–585 (1986).
A. Quaroni, M. M. Weiser, S. Lee, and D. Amodeo. J. Natl. Cancer Inst. 77:405–415 (1986).
P. Bissonnette, A. Blais, and A. Berteloot. Fed. Proc. 46:A5579 (1987).
A. Blais, P. Bissonnette, and A. Berteloot. Gastroenterology 92:1319 (1987).
L. Bergin and A. H. Dantzig. FASEB J. 2:A2646 (1988).
A. H. Dantzig and L. Bergin. FASEB J. 2:A6933 (1988).
C. J. Dix, H. Y. Obray, and G. Wilson. Biochem. Soc. Trans. 15:439–440 (1987).
R. Muthiah and B. Seetharam. J. Cell Biol. 105:235A (1987).
R. L. Ehrmann and G. O. Gey. J. Natl. Cancer Inst. 16:1375–1378 (1956).
E. S. Reynolds. J. Cell Biol. 71:208–212 (1963).
J. M. Robinson and M. J. Karnovsky. J. Histochem. Cytochem. 31:1197–1208 (1983).
I. J. Hidalgo, T. J. Raub, and R. T. Borchardt. Gastroenterology 96:736–749 (1989).
A. H. Dantzig and L. Bergin. Biochem. Biophys. Res. Commun. 155:1082–1087 (1988).
S. M. Albelda, P. M. Sampson, F. R. Haselton, J. M. McNiff, S. N. Mueller, S. K. Williams, A. P. Fishman, and E. M. Levine. J. Appl. Physiol. 64:308–322 (1988).
M. Rousset, G. Chevalier, J. P. Rousset, E. Dessaulx, and A. Zweibaum. Cancer Res. 39:531–534 (1979).
N. F. H. Ho, J. Y. Park, P. F. Ni, and W. I. Higuchi. In W. Crouthamel and A. C. Sugars (eds.), Animal Models for Oral Drug Delivery in Man, Am. Pharm. Assoc., Washington, DC, 1983, pp. 27–106.
N. F. H. Ho, J. Y. Park, W. Morozowich, and W. I. Higuchi. In E. R. Roche (ed.), Design of Biopharmaceutical Properties Through Prodrugs and Analogs, Am. Pharm. Assoc., Washington, DC, 1977, pp. 136–227.
R. A. Conradi, A. R. Hilgers, N. F. H. Ho, and P. S. Burton (submitted for publication).
A. Blais, P. Bissonnette, and A. Berteloot. J. Membrane Biol. 99:113–125 (1987).
H. Westergaard and J. M. Dietschy. J. Clin. Invest. 54:718–732 (1974).
F. A. Wilson and J. M. Dietschy. Biochim. Biophys. Acta 363:112–126 (1974).
K. W. Smithson, D. B. Millar, L. R. Jacobs, and G. M. Gray. Science 241:1241–1244 (1981).
C. H. Von Bonsdorf, S. D. Fuller, and K. Simons. EMBO J. 4:2781–2792 (1985).
N. F. H. Ho, J. S. Day, C. L. Barsuhn, P. S. Burton, and T. J. Raub. J. Control. Release 11:3–24 (1990).
K. E. Knuth, W. Morozowich, and N. F. H. Ho. Pharm. Res. 3:475 (1986).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Hilgers, A.R., Conradi, R.A. & Burton, P.S. Caco-2 Cell Monolayers as a Model for Drug Transport Across the Intestinal Mucosa. Pharm Res 7, 902–910 (1990). https://doi.org/10.1023/A:1015937605100
Issue Date:
DOI: https://doi.org/10.1023/A:1015937605100